1. 139P The timing, dynamics, and co-occurrence of immune-related adverse events with a PD-L1 inhibitor in non-small cell lung cancer. (December 2022) Authors: Smith, K.E.; Pritzl, S.; Yu, W.; Bara, I.; Thanarajasingam, G.; Kaul, M.; Williams, K.A.; Dueck, A.; Mansfield, A.S. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Limitations of fibrosis grade as diagnostic criteria for post polycythemia vera and essential thrombocytosis myelofibrosis. Issue 7 (July 2015) Authors: Gowin, K.; Verstovsek, S.; Daver, N.; Pemmaraju, N.; Valdez, R.; Kosiorek, H.; Dueck, A.; Mesa, R. Journal: Leukemia research Issue: Volume 39:Issue 7(2015:Jul.) Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis. (September 2017) Authors: Gowin, K.; Kosiorek, H.; Dueck, A.; Mascarenhas, J.; Hoffman, R.; Reeder, C.; Camoriano, J.; Tibes, R.; Gano, K.; Palmer, J.; Mesa, R. Journal: Leukemia research Issue: Volume 60(2017:Sep.) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0440: Proton Therapy Reduces Patient-Reported Adverse Events: A Neural Network for Large-Volume Practice. (November 2020) Authors: DeWees, T.; Golafshar, M.; Petersen, M.; Whitaker, T.J.; Amundson, A.; Klein, K.; Pisansky, T.; Davis, B.; Corbin, K.; Stish, B.; Choo, C.R.; Hallemeier, C.; Mutter, R.; Wong, W.; Petersen, I.; Park, S.; Daniels, T.; McGee, L.; Laack, N.; Dueck, A. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Purinergic signaling modulates human visceral adipose inflammatory responses: implications in metabolically unhealthy obesity. Issue 5 (25th February 2015) Authors: Pandolfi, J.; Ferraro, A.; Lerner, M.; Serrano, J.R.; Dueck, A.; Fainboim, L.; Arruvito, L. Journal: Journal of leukocyte biology Issue: Volume 97:Issue 5(2015) Page Start: 941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SERIOUS ADVERSE EVENTS AMONG OLDER PATIENTS IN THE ALTTO TRIAL. (November 2019) Authors: Pondé, N.; Tarh, D.Agbor; Korde, L.; Hilbers, F.; Jackisch, C.; Werner, O.; Gelber, R.; Jatoi, A.; Dueck, A.; Aspitia, A.Moreno; Sotiriou, C.; De Azambuja, E.; Piccart, M.; Dal Lago, L. Journal: Journal of geriatric oncology Issue: Volume 10(2019)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Single-cell and spatially resolved transcriptome analysis reveals cellular heterogeneities and novel regulators of atherosclerotic plaque destabilization. (August 2022) Authors: Pauli, J.; Wu, Z.; Yokota, C.; Winski, G.; Paloschi, V.; Dueck, A.; Engelhardt, S.; Eckstein, H.-H.; Reilly, M.P.; Maegdefessel, L. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗